The American BazaarOpinion

Trigger warning: Pennsylvania’s politicians will find this article offensive

Pennsylvania’s short-term politics threaten its biotech future, driving innovation and opportunity to rival states.
newscase

Pfizer Divests Majority Stake in BioNTech, Signaling Strategic Shift

Five years after their celebrated collaboration on a COVID-19 vaccine, Pfizer has initiated a significant divestment, selling ...
New Atlas

New nanoparticle mRNA vaccine may be cheaper and 100 times more powerful

Researchers at MIT have just developed a new lipid nanoparticle that super-enhances the effectiveness of the mRNA vaccine in ...
newscase

CureVac Investors Face Crucial Vote on BioNTech Acquisition

The future of German biotech firm CureVac hangs in the balance as shareholders prepare for a decisive extraordinary general ...
Technology Networks

New Nanoparticle Could Cut mRNA Vaccine Costs

Researchers showed that an mRNA influenza vaccine delivered with their new lipid nanoparticle could generate the same immune ...
Pharmabiz

Primrose Bio introduces Prima RNApols ExTend Cap AU, a next-gen RNA polymerase for self-amplifying mRNA

Primrose Bio introduces Prima RNApols ExTend Cap AU, a next-gen RNA polymerase for self-amplifying mRNA: San Diego, California Tuesday, November 11, 2025, 12:00 Hrs [IST] Primrose ...
Nanowerk

Nanoparticles boost mRNA delivery, lowering vaccine doses and overall cost

A new lipid nanoparticle could make mRNA vaccines more powerful and potentially lower the cost per vaccine dose.

Primrose Bio Launches Prima RNApols™ ExTend Cap AU, a Next-Gen RNA Polymerase for Self-Amplifying mRNA

Maximize capping efficiency and minimize double-stranded RNA ("dsRNA") in the manufacturing of self-amplifying mRNA SAN DIEGO ...

Nanoparticles that enhance mRNA delivery could reduce vaccine dosage and costs

A new delivery particle developed at MIT could make mRNA vaccines more effective and potentially lower the cost per vaccine ...